Jefferies Financial Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-69,314
| Closed | -$1.42M | – | 1198 |
|
|
2024
Q1 | $1.42M | Sell |
69,314
-96,013
| -58% | -$1.97M | 0.01% | 488 |
|
|
2023
Q4 | $3.55M | Buy |
165,327
+152,527
| +1,192% | +$3.27M | 0.02% | 318 |
|
|
2023
Q3 | $264K | Buy |
+12,800
| New | +$264K | ﹤0.01% | 865 |
|
|
2023
Q2 | – | Sell |
-263,123
| Closed | -$6.06M | – | 1253 |
|
|
2023
Q1 | $6.06M | Buy |
+263,123
| New | +$6.06M | 0.05% | 156 |
|